NO20004220L - Inhibitors of phospholipase enzymes - Google Patents
Inhibitors of phospholipase enzymesInfo
- Publication number
- NO20004220L NO20004220L NO20004220A NO20004220A NO20004220L NO 20004220 L NO20004220 L NO 20004220L NO 20004220 A NO20004220 A NO 20004220A NO 20004220 A NO20004220 A NO 20004220A NO 20004220 L NO20004220 L NO 20004220L
- Authority
- NO
- Norway
- Prior art keywords
- inhibitors
- phospholipase enzymes
- phospholipase
- enzymes
- Prior art date
Links
- 102000015439 Phospholipases Human genes 0.000 title 1
- 108010064785 Phospholipases Proteins 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/12—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3006298A | 1998-02-25 | 1998-02-25 | |
| PCT/US1999/003899 WO1999043651A2 (en) | 1998-02-25 | 1999-02-24 | Inhibitors of phospholipase enzymes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20004220D0 NO20004220D0 (en) | 2000-08-23 |
| NO20004220L true NO20004220L (en) | 2000-10-05 |
Family
ID=21852314
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20004220A NO20004220L (en) | 1998-02-25 | 2000-08-23 | Inhibitors of phospholipase enzymes |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP1056719A2 (en) |
| JP (1) | JP2002504539A (en) |
| KR (1) | KR20010041343A (en) |
| CN (1) | CN1299347A (en) |
| AU (1) | AU2782699A (en) |
| BG (1) | BG104780A (en) |
| BR (1) | BR9908280A (en) |
| CA (1) | CA2322161A1 (en) |
| EA (1) | EA200000868A1 (en) |
| EE (1) | EE200000486A (en) |
| HR (1) | HRP20000552A2 (en) |
| HU (1) | HUP0100757A3 (en) |
| ID (1) | ID27280A (en) |
| IL (1) | IL137718A0 (en) |
| NO (1) | NO20004220L (en) |
| PL (1) | PL342995A1 (en) |
| SK (1) | SK12742000A3 (en) |
| TR (1) | TR200002446T2 (en) |
| WO (1) | WO1999043651A2 (en) |
Families Citing this family (70)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2370805C (en) * | 1999-05-05 | 2012-07-03 | Aventis Pharma Limited | Ureas as cell adhesion modulators |
| DE60128475T2 (en) | 2000-07-25 | 2008-02-07 | Merck & Co., Inc. | N-SUBSTITUTED INDOLE USED IN THE TREATMENT OF DIABETES |
| US6855722B2 (en) | 2001-01-29 | 2005-02-15 | Dimensional Pharmaceuticals, Inc. | Substituted indoles and their use as integrin antagonists |
| WO2002090314A1 (en) | 2001-05-03 | 2002-11-14 | Galileo Laboratories, Inc. | Pyruvate derivatives |
| US6608196B2 (en) | 2001-05-03 | 2003-08-19 | Galileo Pharmaceuticals, Inc. | Process for solid supported synthesis of pyruvate-derived compounds |
| TWI224101B (en) | 2001-06-20 | 2004-11-21 | Wyeth Corp | Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1) |
| PT1397130E (en) | 2001-06-20 | 2007-11-13 | Wyeth Corp | Substituted indole acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
| US7291639B2 (en) | 2001-06-20 | 2007-11-06 | Wyeth | Aryloxy-acetic acid compounds useful as inhibitors of plasminogen activator inhibitor-1 (PAI-1) |
| WO2003000668A1 (en) * | 2001-06-25 | 2003-01-03 | Nippon Soda Co., Ltd. | Oxa(thia)zolidine compounds, process for preparation thereof and anti-inflammatory agents |
| SI1451154T1 (en) * | 2001-12-03 | 2008-06-30 | Wyeth Corp | Inhibitors of cytosolic phospholipase a2 |
| DK1892239T3 (en) * | 2001-12-03 | 2013-03-25 | Wyeth Llc | Inhibitors of cytosol phospholipase A2 |
| US6984735B2 (en) | 2001-12-03 | 2006-01-10 | Wyeth | Process for making an aldehyde |
| US7605156B2 (en) | 2001-12-03 | 2009-10-20 | Wyeth | Methods for the use of inhibitors of cytosolic phospholipase A2 |
| US7713964B2 (en) | 2001-12-03 | 2010-05-11 | Wyeth Llc | Methods for treating asthmatic conditions |
| US7101875B2 (en) | 2001-12-03 | 2006-09-05 | Wyeth | Methods for treating arthritic disorders |
| US6797708B2 (en) | 2001-12-03 | 2004-09-28 | Wyeth | Inhibitors of cytosolic phospholipase A2 |
| US6635771B2 (en) | 2001-12-03 | 2003-10-21 | Wyeth | N-benzhydryl indole compounds |
| AUPS282602A0 (en) | 2002-06-07 | 2002-06-27 | Garvan Institute Of Medical Research | Method of inhibiting cell proliferation |
| RU2328483C2 (en) | 2002-08-29 | 2008-07-10 | Мерк Энд Ко., Инк. | Indoles with antidiabetic activity |
| CA2495915A1 (en) | 2002-08-29 | 2004-03-11 | Merck & Co., Inc. | Indoles having anti-diabetic activity |
| DE60332769D1 (en) | 2002-11-07 | 2010-07-08 | Organon Nv | INDOLE FOR TREATING DISEASES RELATED TO THE ANDROGEN RECEPTOR |
| DE60324183D1 (en) | 2002-12-10 | 2008-11-27 | Wyeth Corp | Aryl-, aryloxy- und alkyloxysubstituierte 1h-indol-3-yl-glyoxylsäurederivateals inhibitoren des plasminogenaktivatorinhibitors-1 (pai-1) |
| AU2003296323A1 (en) | 2002-12-10 | 2004-06-30 | Wyeth | Substituted indole oxo-acetyl amino acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
| UA80453C2 (en) | 2002-12-10 | 2007-09-25 | Derivatives of substituted dyhydropyranoindol-3,4-dion as inhibitors of plasminogen activator inhibitor-1 (pai-1) | |
| US7078429B2 (en) | 2002-12-10 | 2006-07-18 | Wyeth | Substituted 3-carbonyl-1H-indol-1-yl acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) |
| MXPA05006282A (en) | 2002-12-10 | 2005-08-19 | Wyeth Corp | Substituted 3-alkyl and 3-arylalkyl 1h. |
| TW200510305A (en) * | 2003-07-25 | 2005-03-16 | Wyeth Corp | Process for the preparation of CPLA2 inhibitors |
| US7534894B2 (en) | 2003-09-25 | 2009-05-19 | Wyeth | Biphenyloxy-acids |
| US7265148B2 (en) | 2003-09-25 | 2007-09-04 | Wyeth | Substituted pyrrole-indoles |
| US7268159B2 (en) | 2003-09-25 | 2007-09-11 | Wyeth | Substituted indoles |
| US7446201B2 (en) | 2003-09-25 | 2008-11-04 | Wyeth | Substituted heteroaryl benzofuran acids |
| US7420083B2 (en) | 2003-09-25 | 2008-09-02 | Wyeth | Substituted aryloximes |
| US7332521B2 (en) | 2003-09-25 | 2008-02-19 | Wyeth | Substituted indoles |
| US7582773B2 (en) | 2003-09-25 | 2009-09-01 | Wyeth | Substituted phenyl indoles |
| US7442805B2 (en) | 2003-09-25 | 2008-10-28 | Wyeth | Substituted sulfonamide-indoles |
| US7141592B2 (en) | 2003-09-25 | 2006-11-28 | Wyeth | Substituted oxadiazolidinediones |
| US7351726B2 (en) | 2003-09-25 | 2008-04-01 | Wyeth | Substituted oxadiazolidinediones |
| US7163954B2 (en) | 2003-09-25 | 2007-01-16 | Wyeth | Substituted naphthyl benzothiophene acids |
| US7342039B2 (en) | 2003-09-25 | 2008-03-11 | Wyeth | Substituted indole oximes |
| US7411083B2 (en) | 2003-09-25 | 2008-08-12 | Wyeth | Substituted acetic acid derivatives |
| GB0324763D0 (en) | 2003-10-23 | 2003-11-26 | Oxagen Ltd | Use of compounds in therapy |
| TW200602317A (en) | 2004-04-23 | 2006-01-16 | Akzo Nobel Nv | Novel androgens |
| RU2007101705A (en) | 2004-06-18 | 2008-07-27 | Биолипокс Аб (Se) | INDOS USEFUL FOR TREATING INFLAMMATION |
| BRPI0514572A (en) | 2004-08-23 | 2008-06-17 | Wyeth Corp | thiazole naphthyl acids |
| US7754747B2 (en) | 2004-08-23 | 2010-07-13 | Wyeth Llc | Oxazolo-naphthyl acids |
| MX2007002177A (en) | 2004-08-23 | 2007-04-02 | Wyeth Corp | Pyrrolo-naphthyl acids as pai-1 inhibitors. |
| RU2394027C2 (en) * | 2004-10-27 | 2010-07-10 | Ф. Хоффманн-Ля Рош Аг | Novel indole or benzimidazole derivatives |
| ZA200705827B (en) | 2005-01-19 | 2008-10-29 | Biolipox Ab | Indoles useful in the treatment of inflammation |
| US7777040B2 (en) | 2005-05-03 | 2010-08-17 | Cgi Pharmaceuticals, Inc. | Certain substituted ureas, as modulators of kinase activity |
| TW200718687A (en) | 2005-05-27 | 2007-05-16 | Wyeth Corp | Inhibitors of cytosolic phospholipase A2 |
| MX2008002117A (en) | 2005-08-17 | 2008-09-26 | Wyeth Corp | Substituted indoles and use thereof. |
| WO2009093029A1 (en) | 2008-01-22 | 2009-07-30 | Oxagen Limited | Compounds having crth2 antagonist activity |
| AR072297A1 (en) | 2008-06-27 | 2010-08-18 | Novartis Ag | DERIVATIVES OF INDOL-2-IL-PIRIDIN-3-ILO, PHARMACEUTICAL COMPOSITION THAT INCLUDES THEM AND ITS USE IN MEDICINES FOR THE TREATMENT OF DISEASES MEDIATED BY THE SYNTHESIS ALDOSTERONE. |
| PL2448938T3 (en) | 2009-06-29 | 2014-11-28 | Incyte Holdings Corp | Pyrimidinones as pi3k inhibitors |
| WO2011075643A1 (en) | 2009-12-18 | 2011-06-23 | Incyte Corporation | Substituted heteroaryl fused derivatives as pi3k inhibitors |
| CA2796311A1 (en) | 2010-04-14 | 2011-10-20 | Incyte Corporation | Fused derivatives as pi3k.delta. inhibitors |
| US9062055B2 (en) | 2010-06-21 | 2015-06-23 | Incyte Corporation | Fused pyrrole derivatives as PI3K inhibitors |
| CA2822070C (en) | 2010-12-20 | 2019-09-17 | Incyte Corporation | N-(1-(substituted-phenyl)ethyl)-9h-purin-6-amines as pi3k inhibitors |
| WO2012125629A1 (en) | 2011-03-14 | 2012-09-20 | Incyte Corporation | Substituted diamino-pyrimidine and diamino-pyridine derivatives as pi3k inhibitors |
| WO2012135009A1 (en) | 2011-03-25 | 2012-10-04 | Incyte Corporation | Pyrimidine-4,6-diamine derivatives as pi3k inhibitors |
| PH12021552978A1 (en) | 2011-09-02 | 2022-08-22 | Incyte Holdings Corp | Heterocyclylamines as pi3k inhibitors |
| AR090548A1 (en) | 2012-04-02 | 2014-11-19 | Incyte Corp | BICYCLIC AZAHETEROCICLOBENCILAMINS AS PI3K INHIBITORS |
| BR112015000940B1 (en) | 2012-07-17 | 2022-05-17 | Glaxosmithkline Intellectual Property (No. 2) Limited | Compound, pharmaceutical composition, and use of a compound |
| GB201322273D0 (en) | 2013-12-17 | 2014-01-29 | Atopix Therapeutics Ltd | Process |
| US10077277B2 (en) | 2014-06-11 | 2018-09-18 | Incyte Corporation | Bicyclic heteroarylaminoalkyl phenyl derivatives as PI3K inhibitors |
| LT3262046T (en) | 2015-02-27 | 2021-01-11 | Incyte Corporation | Salts of pi3k inhibitor and processes for their preparation |
| WO2016183060A1 (en) | 2015-05-11 | 2016-11-17 | Incyte Corporation | Process for the synthesis of a phosphoinositide 3-kinase inhibitor |
| US9988401B2 (en) | 2015-05-11 | 2018-06-05 | Incyte Corporation | Crystalline forms of a PI3K inhibitor |
| CA3101323A1 (en) | 2018-06-01 | 2019-12-05 | Incyte Corporation | Dosing regimen for the treatment of pi3k related disorders |
| HUE066335T2 (en) | 2018-10-05 | 2024-07-28 | Annapurna Bio Inc | Compounds and compositions for treating conditions associated with apj receptor activity |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE314373B (en) * | 1966-04-12 | 1969-09-08 | Sumitomo Chemical Co | |
| FR1492929A (en) * | 1966-05-11 | 1967-08-25 | Roussel Uclaf | Novel substituted 1- (omega-carboxyalkyl) indoles and method of preparation |
| US3505354A (en) * | 1967-05-18 | 1970-04-07 | Geigy Chem Corp | 2-methyl-3-p-halobenzoylindole-n-aliphatic acids |
| DE1816335A1 (en) * | 1968-12-21 | 1970-07-09 | Thiemann Gmbh Chem Pharm Fabri | 2-methyl-5-alkoxy-3-acyl-indole-1-acetic - acid and esters thereof |
| US4894386A (en) * | 1987-04-15 | 1990-01-16 | Ici Americas Inc. | Aliphatic carboxamides |
| CA1337202C (en) * | 1988-04-13 | 1995-10-03 | Victor Giulio Matassa | Cyclic amides which are leukotriene antagonists |
| US5420289A (en) * | 1989-10-27 | 1995-05-30 | American Home Products Corporation | Substituted indole-, indene-, pyranoindole- and tetrahydrocarbazole-alkanoic acid derivatives as inhibitors of PLA2 and lipoxygenase |
| US5290798A (en) * | 1991-09-30 | 1994-03-01 | Merck Frosst Canada, Inc. | (hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis |
| DE69314786T2 (en) * | 1992-05-13 | 1998-02-19 | Syntex (U.S.A.) Inc., Palo Alto, Calif. | SUBSTITUTED INDOLE AS ANGIOTENSIN II ANTAGONISTS |
| IL109311A0 (en) * | 1993-04-16 | 1994-07-31 | Lilly Co Eli | 1H-indole-3-acetamide sPla2 inhibitors |
| DE4338770A1 (en) * | 1993-11-12 | 1995-05-18 | Matthias Dr Lehr | Indole-2-alkanoic acids and their derivatives as inhibitors of phospholipase A¶2¶ |
| WO1998005637A1 (en) * | 1996-08-01 | 1998-02-12 | Merckle Gmbh | Acylpyrroldicarboxylic acids and acylindoldicarboxylic acids and their derivatives and inhibitors of the cytosolic phospholipase a¿2? |
| WO1998008818A1 (en) * | 1996-08-26 | 1998-03-05 | Genetics Institute, Inc. | Inhibitors of phospholipase enzymes |
-
1999
- 1999-02-24 KR KR1020007009456A patent/KR20010041343A/en not_active Withdrawn
- 1999-02-24 CN CN99805385A patent/CN1299347A/en active Pending
- 1999-02-24 HR HR20000552A patent/HRP20000552A2/en not_active Application Discontinuation
- 1999-02-24 HU HU0100757A patent/HUP0100757A3/en unknown
- 1999-02-24 IL IL13771899A patent/IL137718A0/en unknown
- 1999-02-24 ID IDW20001594A patent/ID27280A/en unknown
- 1999-02-24 EA EA200000868A patent/EA200000868A1/en unknown
- 1999-02-24 WO PCT/US1999/003899 patent/WO1999043651A2/en not_active Ceased
- 1999-02-24 JP JP2000533409A patent/JP2002504539A/en not_active Withdrawn
- 1999-02-24 BR BR9908280-2A patent/BR9908280A/en not_active IP Right Cessation
- 1999-02-24 TR TR2000/02446T patent/TR200002446T2/en unknown
- 1999-02-24 EP EP99908379A patent/EP1056719A2/en not_active Withdrawn
- 1999-02-24 EE EEP200000486A patent/EE200000486A/en unknown
- 1999-02-24 AU AU27826/99A patent/AU2782699A/en not_active Abandoned
- 1999-02-24 SK SK1274-2000A patent/SK12742000A3/en unknown
- 1999-02-24 PL PL99342995A patent/PL342995A1/en unknown
- 1999-02-24 CA CA002322161A patent/CA2322161A1/en not_active Abandoned
-
2000
- 2000-08-23 NO NO20004220A patent/NO20004220L/en unknown
- 2000-09-19 BG BG104780A patent/BG104780A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EE200000486A (en) | 2002-02-15 |
| EP1056719A2 (en) | 2000-12-06 |
| IL137718A0 (en) | 2001-10-31 |
| AU2782699A (en) | 1999-09-15 |
| BG104780A (en) | 2001-10-31 |
| HUP0100757A1 (en) | 2001-08-28 |
| TR200002446T2 (en) | 2000-12-21 |
| BR9908280A (en) | 2000-10-31 |
| KR20010041343A (en) | 2001-05-15 |
| WO1999043651A3 (en) | 1999-12-16 |
| EA200000868A1 (en) | 2001-04-23 |
| ID27280A (en) | 2001-03-22 |
| HUP0100757A3 (en) | 2001-11-28 |
| PL342995A1 (en) | 2001-07-16 |
| WO1999043651A2 (en) | 1999-09-02 |
| CN1299347A (en) | 2001-06-13 |
| JP2002504539A (en) | 2002-02-12 |
| HRP20000552A2 (en) | 2001-04-30 |
| SK12742000A3 (en) | 2001-05-10 |
| NO20004220D0 (en) | 2000-08-23 |
| CA2322161A1 (en) | 1999-09-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20004219D0 (en) | Inhibitors of phospholipase enzymes | |
| NO20004220D0 (en) | Inhibitors of phospholipase enzymes | |
| NO20004217D0 (en) | Inhibitors of phospholipase A2 | |
| NO20004550D0 (en) | Enzyme inhibitors | |
| NO20014535D0 (en) | Inhibitors of IMPDH enzyme | |
| EP1127054A4 (en) | Novel inhibitors of impdh enzyme | |
| NO20012984D0 (en) | Succinoylamino benzodiazepines as inhibitors of AB protein production | |
| DK1131416T3 (en) | Lipolytic Enzyme Variants | |
| AU3665199A (en) | Inhibitors of impdh enzyme | |
| NO993717L (en) | Use of gastrointestinal lipase inhibitors | |
| FI965019A7 (en) | Enzyme inhibitors | |
| PT1086076E (en) | SULFONAMIDE INHIBITORS OF ASPARTIL PROTEASE | |
| FI964137A0 (en) | Inhibitors of rotamase enzyme activity | |
| FI951553L (en) | 1H-indole-glyoxylamide sPLA2 inhibitors | |
| EE200000386A (en) | Prodrugs of aspartyl protease inhibitors | |
| PT927183E (en) | SPIROCYLIC INHIBITORS OF METALOPROTEASES | |
| NO20016034D0 (en) | Inhibitors of aspartyl protease | |
| HUP0101640A3 (en) | Certain thoil inhibitors of endothelin-converting enzyme | |
| FR2816843B1 (en) | INHIBITORS OF ENZYME 5 ALPHA-REDUCTASE | |
| DE60038350D1 (en) | Angiotensin-converting enzyme inhibitors | |
| DE60024101D1 (en) | ENZYME INHIBITORS | |
| ID28032A (en) | TRICICLIC OF PIPERIDIN-Δ3-AS ANTAGONIS-α2 | |
| NO20004664D0 (en) | Method of Preparation of HIV Protease Inhibitors | |
| EP1379633A4 (en) | ENZYMATIC MODIFICATION OF PSYLLIUM | |
| HK1030209A (en) | Inhibitors of phospholipase enzymes |